Evidence map›Paper›PMID 40955211›Full record

ReviewCureus2025

Origin, Impact, and Solutions for Lifestyle-Related Diseases in Japan.

David Cai, Mohsin Yakub

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David CaiMedicine, California University of Science and Medicine, Colton, USA.
Mohsin YakubMedical Education/Physiology, Nutrition, California University of Science and Medicine, Colton, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japan is an archipelago west of the Pacific Ocean, facing decades of dietary and lifestyle westernization and its physiological consequences. Much like many other countries, Japan is tackling the global trend of lifestyle-related problems. This paper aims to discuss the current demographics in Japan and examine the origin and impact of lifestyle-related chronic diseases within the population. This review will highlight the nutritional transition during the country's development and examine the pathogenesis and pathophysiology of lifestyle-related diseases, primarily hypertension and obesity, in the context of traditional practices and cultural shifts. A combination of high salt intake in traditional cuisine and increased fat and sugar consumption from the westernization of the diet contributes to elevated blood pressures and obesity rates in Japan. This paper explores policy-based interventions, such as nutrient taxation and front-of-package labeling (FOPL), and their potential to mitigate these growing health concerns. One strategy is a nutrient tax to reduce the appeal of specific unhealthy products, such as sugar-sweetened beverages. Similarly, targeting alcohol with taxes and stricter regulations on advertising can reduce consumption. FOPL provides clear and concise nutritional information on the front of each product for consumers to make informed purchases. Expansion of blood pressure monitoring can allow patients to take a more proactive role in their own health, and providers can better tailor treatment plans. Increasing physical activity through workplace wellness programs can reduce the risk of chronic diseases and can be especially effective for Japanese office workers who tend to spend a lot of time in sedentary behavior. Collaboration amongst the government, businesses, and healthcare providers will be vital to empowering the general population to make healthy changes.

Indexed as

chronic diseasehypertensionjapanlifestyle medicinenutritionobesity

Identifiers

PMID40955211
PMCPMC12433719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.